302 Found

CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 589278-589688 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T4648","span":{"begin":0,"end":410},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Lymphocytes were studied using indirect immunofluorescence methods employing monoclonal antibodies to CD-markers CD4, CD8, CD16, CD25, CD95, HLA-I, and HLA-II, from the blood of 14 volunteers (aged 18-24 years) before UV exposure (control), after an exposure of blood in vitro to a dose 1.12 kJ, and after 24 hours of exposure of the medial surface of the elbow joint in vivo (S=200 cm2), to a dose of 1.12 kJ."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T39","span":{"begin":0,"end":410},"obj":"Sentence"}],"text":"Lymphocytes were studied using indirect immunofluorescence methods employing monoclonal antibodies to CD-markers CD4, CD8, CD16, CD25, CD95, HLA-I, and HLA-II, from the blood of 14 volunteers (aged 18-24 years) before UV exposure (control), after an exposure of blood in vitro to a dose 1.12 kJ, and after 24 hours of exposure of the medial surface of the elbow joint in vivo (S=200 cm2), to a dose of 1.12 kJ."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5526","span":{"begin":102,"end":104},"obj":"Disease"}],"attributes":[{"id":"A5526","pred":"mondo_id","subj":"T5526","obj":"http://purl.obolibrary.org/obo/MONDO_0005130"},{"id":"A5527","pred":"mondo_id","subj":"T5526","obj":"http://purl.obolibrary.org/obo/MONDO_0005480"}],"text":"Lymphocytes were studied using indirect immunofluorescence methods employing monoclonal antibodies to CD-markers CD4, CD8, CD16, CD25, CD95, HLA-I, and HLA-II, from the blood of 14 volunteers (aged 18-24 years) before UV exposure (control), after an exposure of blood in vitro to a dose 1.12 kJ, and after 24 hours of exposure of the medial surface of the elbow joint in vivo (S=200 cm2), to a dose of 1.12 kJ."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T2961","span":{"begin":102,"end":104},"obj":"Phenotype"}],"attributes":[{"id":"A2961","pred":"hp_id","subj":"T2961","obj":"http://purl.obolibrary.org/obo/HP_0002608"},{"id":"A2962","pred":"hp_id","subj":"T2961","obj":"http://purl.obolibrary.org/obo/HP_0032282"}],"text":"Lymphocytes were studied using indirect immunofluorescence methods employing monoclonal antibodies to CD-markers CD4, CD8, CD16, CD25, CD95, HLA-I, and HLA-II, from the blood of 14 volunteers (aged 18-24 years) before UV exposure (control), after an exposure of blood in vitro to a dose 1.12 kJ, and after 24 hours of exposure of the medial surface of the elbow joint in vivo (S=200 cm2), to a dose of 1.12 kJ."}

    CORD-19-PD-UBERON

    {"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1165","span":{"begin":169,"end":174},"obj":"Body_part"},{"id":"T1166","span":{"begin":262,"end":267},"obj":"Body_part"},{"id":"T1167","span":{"begin":356,"end":367},"obj":"Body_part"},{"id":"T1168","span":{"begin":356,"end":361},"obj":"Body_part"}],"attributes":[{"id":"A1165","pred":"uberon_id","subj":"T1165","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A1166","pred":"uberon_id","subj":"T1166","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A1167","pred":"uberon_id","subj":"T1167","obj":"http://purl.obolibrary.org/obo/UBERON_0001490"},{"id":"A1168","pred":"uberon_id","subj":"T1168","obj":"http://purl.obolibrary.org/obo/UBERON_0001461"}],"text":"Lymphocytes were studied using indirect immunofluorescence methods employing monoclonal antibodies to CD-markers CD4, CD8, CD16, CD25, CD95, HLA-I, and HLA-II, from the blood of 14 volunteers (aged 18-24 years) before UV exposure (control), after an exposure of blood in vitro to a dose 1.12 kJ, and after 24 hours of exposure of the medial surface of the elbow joint in vivo (S=200 cm2), to a dose of 1.12 kJ."}